Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;35(23):e2207877.
doi: 10.1002/adma.202207877. Epub 2023 Apr 25.

Localized Nanoparticle-Mediated Delivery of miR-29b Normalizes the Dysregulation of Bone Homeostasis Caused by Osteosarcoma whilst Simultaneously Inhibiting Tumor Growth

Fiona E Freeman  1   2   3   4   5   6   7 , Pere Dosta  3   4   8 , Lianne C Shanley  1   5   9 , Natalia Ramirez Tamez  4 , Cristobal J Riojas Javelly  4 , Olwyn R Mahon  1   10 , Daniel J Kelly  1   2   5   11 , Natalie Artzi  3   4   8
Affiliations

Localized Nanoparticle-Mediated Delivery of miR-29b Normalizes the Dysregulation of Bone Homeostasis Caused by Osteosarcoma whilst Simultaneously Inhibiting Tumor Growth

Fiona E Freeman et al. Adv Mater. 2023 Jun.

Abstract

Patients diagnosed with osteosarcoma undergo extensive surgical intervention and chemotherapy resulting in dismal prognosis and compromised quality of life owing to poor bone regeneration, which is further compromised with chemotherapy delivery. This study aims to investigate if localized delivery of miR-29b-which is shown to promote bone formation by inducing osteoblast differentiation and also to suppress prostate and cervical tumor growth-can suppress osteosarcoma tumors whilst simultaneously normalizing the dysregulation of bone homeostasis caused by osteosarcoma. Thus, the therapeutic potential of microRNA (miR)-29b is studied to promote bone remodeling in an orthotopic model of osteosarcoma (rather than in bone defect models using healthy mice), and in the context of chemotherapy, that is clinically relevant. A formulation of miR-29b:nanoparticles are developed that are delivered via a hyaluronic-based hydrogel to enable local and sustained release of the therapy and to study the potential of attenuating tumor growth whilst normalizing bone homeostasis. It is found that when miR-29b is delivered along with systemic chemotherapy, compared to chemotherapy alone, the therapy provided a significant decrease in tumor burden, an increase in mouse survival, and a significant decrease in osteolysis thereby normalizing the dysregulation of bone lysis activity caused by the tumor.

Keywords: biomaterials; bone regenerations; microRNAs; nanoparticles; osteosarcoma.

PubMed Disclaimer

References

    1. A. Misaghi, A. Goldin, M. Awad, A. A. Kulidjian, SICOT J. 2018, 4, 12.
    1. The Ortho Factbook, 2nd ed. Knowledge Enterprises Inc, Chagrin Falls, OH, USA 2001.
    1. a) T. M. Fan, R. D. Roberts, M. M. Lizardo, Front. Oncol. 2020, 10, 13;
    1. b) K. Winkler, G. Beron, G. Delling, U. Heise, H. Kabisch, C. Purfürst, J. Berger, J. Ritter, H. Jürgens, V. Gerein, J. Clin. Oncol. 1988, 6, 329;
    1. c) N. M. Marina, S. Smeland, S. S. Bielack, M. Bernstein, G. Jovic, M. D. Krailo, J. M. Hook, C. Arndt, H. van den Berg, B. Brennan, B. Brichard, K. L. B. Brown, T. Butterfass-Bahloul, G. Calaminus, H. E. Daldrup-Link, M. Eriksson, M. C. Gebhardt, H. Gelderblom, J. Gerss, R. Goldsby, A. Goorin, R. Gorlick, H. E. Grier, J. P. Hale, K. S. Hall, J. Hardes, D. S. Hawkins, K. Helmke, P. C. W. Hogendoorn, M. S. Isakoff, Lancet Oncol. 2016, 17, 1396;

LinkOut - more resources